Background
Breast cancer is the most frequent and most deadly cancer in females and incidence rates are increasing at an alarming rate in Saudi Arabia [1] . Studies have shown the potential of gene expression profiling in discovering biomarkers and molecular genetic signatures for breast cancer [2] [3] [4] . However, such discoveries and association of expression profiling with different type of Saudi Arabian breast cancer patients are largely unexplored.
Materials and methods
We performed transcriptomic profiling of 42 surgicallyresected breast tumors (n=23 lymph node positive; n=19 lymph node negative) using Affymetrix Gene 1.0 ST chip.
Partek Genome Suit 6.4 and Ingenuity Pathway Analysis package were used for identification of differentially expressed genes, hierarchical clustering, gene ontology, pathway analysis and establishing clinical significance.
Results
We identified 30 differentially expressed genes, including 10 up and 20 down-regulated in lymph node involved breast cancer using cut off of p value <0.05 and fold change >2. Ceruloplasmin (CP), immunoglobulin J polypeptide (IJP), cellular retinoic acid binding protein 1 (CRABP1), keratin 23 (KRT23), paraoxonase 3 (PON3), and integrin beta 6 (ITGB6) genes were up-regulated whereas genes like AF4/FMR2 family member 3 (AFF3), v-erb-a erythroblastic leukemia viral oncogene homolog
Conclusions
In the present study, we identified transcriptomic signature in Saudi breast cancer patients that is associated with lymph node metastasis. Our analysis reveals appropriate biological relevance and a number of molecular pathways that may serve as targets for novel therapeutics.
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